HDST-M Share Price Performance
₪0.73
0.32 (80.05%)
Price ₪0.73
Share Pricen/a
HBL - Hadasit Bio-Holdings Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
HDST-M Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
HBL - Hadasit Bio-Holdings Ltd Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.15
- 100.00%
- -4,369.23%
- -6,070.6%
About HDST-M
- Founded
- 2005
- Employees
- 1
- CEO
- WebsiteView website
HBL - Hadasit Bio-Holdings Ltd engages in the medical and biotechnology research and development activities in Israel. The company’s portfolios are developing novel protein drugs for cancer immunotherapy and stem cell-based therapies for the treatment of eye diseases. It also involved in the development of treatments for cancer and autoimmune diseases; cell therapy in autoimmune and inflammatory conditions for the treatment of graft-versus-host disease (GVHD) in bone marrow transplants, treatment of sepsis as well as for coronavirus patients in severe conditions, combination therapy with cancer drugs as well as other inflammatory and autoimmune diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
